Anti-Human EBV positive nasopharyngeal carcinoma Aptamer(Cat#: CTWZ-0124-WZ68)

This product is an aptamer which binds to Human EBV positive nasopharyngeal carcinoma with an affinity of 1-50 nM.

Datasheet MSDS COA
Specific Inquiry 
Size
5’ Modification
 
3’ Modification
 
Add To
Online Inquiry

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number

TOP
Summary

Specifications
Target Category Cell
Target EBV positive nasopharyngeal carcinoma
Alternative Names EBV positive NPC
Target Overview Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated malignancy and has a distinct geographical distribution. EBV infection alters gene expression patterns of host cells through genetic and epigenetic regulations, making EBV positive NPC cells distinct from EBV negative NPC and normal cells.
Type DNA
Species Reactivity Human
Length 50-100 nt
Affinity (Kd) 1-50 nM
Binding Conditions/Buffer DPBS with 4.5 g/L glucose and 5 mMMgCl2, 100 mg/L yeast tRNA, and 1 g/L BSA
GC Content 51.22%
Molecular Weight 24762.1 g/mole
nmoles/OD260 1.138
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
Online Inquiry
×